More tools:Markets·Screener·Research·Chat

Virax Biolabs Group Limited Ordinary Shares (VRAX) Financial Statements

Virax Biolabs Group Limited Ordinary Shares
SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
FIGI BBG0166WT4F2
XNAS · usd
2.63▲ 0.00 (0.19%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close2.63
Day's Range2.56 – 2.66
52-Week Range0.10 – 13.19
Volume28.5K
Avg Volume657.8K
Share Statistics
Shares Outstanding
Employees19
ExchangeXNAS
Listed2022-07-21
Share count as of March 31, 2026
Loading Income Statement…
Key questions about Virax Biolabs Group Limited Ordinary Shares (VRAX)
What is Virax Biolabs Group Limited Ordinary Shares's Market Cap?
Virax Biolabs Group Limited Ordinary Shares's Market Cap is $1.5M, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's Enterprise Value?
Virax Biolabs Group Limited Ordinary Shares's Enterprise Value is -$4.9M, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's Price / Sales?
Virax Biolabs Group Limited Ordinary Shares's Price / Sales is 122.6×, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's EV / Revenue?
Virax Biolabs Group Limited Ordinary Shares's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's EV / EBITDA?
Virax Biolabs Group Limited Ordinary Shares's EV / EBITDA is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's Revenue (TTM)?
Virax Biolabs Group Limited Ordinary Shares's Revenue (TTM) is $12.4K, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's Net Income (TTM)?
Virax Biolabs Group Limited Ordinary Shares's Net Income (TTM) is -$5.0M, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's EBITDA?
Virax Biolabs Group Limited Ordinary Shares's EBITDA is -$6.0M, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's Diluted EPS (TTM)?
Virax Biolabs Group Limited Ordinary Shares's Diluted EPS (TTM) is -8.69, based on as-reported figures from SEC (XBRL) filings.
What is Virax Biolabs Group Limited Ordinary Shares's EBITDA Margin?
Virax Biolabs Group Limited Ordinary Shares's EBITDA Margin is -48607.4%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021
Profit or loss [abstract]
Revenue
Cost of revenue
Gross profit (loss)
Operating expenses:
General and administrative
Research & development
Impairment of intangible asset
Total operating expenses
Operating loss
Other income (expense):
Interest expense, net
Other income (expense), net
Foreign currency gain (loss), net
Total other income (expense), net
Loss before income taxes
Income tax benefit
Net loss
Net loss attributable to non-controlling interest
Net loss attributable to Virax Biolabs shareholders
Comprehensive loss attributable to non-controlling interest
Comprehensive loss attributable to Virax Biolabs shareholders